New standard sets requirements to be used by laboratories for the validation of probabilistic genotyping systems related to interpreting autosomal STR results
VERSANT® HCV Genotype 2.0 Assay (LiPA) provides improved accuracy in identification of HCV genotype and subtype for guiding selection of optimal therapeutic treatment for individuals with Hepatitis C